GBR investigates Brazil's chemical sector amidst a period of political and economic instability.
Massachusetts offers perhaps the most attractive environment for biopharmaceutical research and development in the world, and is fast closing the gap with its rival supercluster in California.
Ontario must upgrade its established advanced manufacturing industry, embrace disruptive technologies and promote innovation.
In a time of uncertainty across the board, the United States is still "going boldly” ahead, bringing us innovation and constantly adapting its business model.
With a limited pool of labor and rising costs, Singapore seeks to develop disruptive manufacturing technologies in order to retain its competitive edge.
Exploration projects in British Columbia continue to take off, as juniors and investors acknowledge the strengths and competitive advantages that operating in this province entails.
